More PYC Therapeutics Limited news
PYC Therapeutics LimitedASX: PYC

Quarterly Update and Appendix 4C

Oct 25, 2017 at 1:50 AM EDT · Issued by PYC Therapeutics Limited

Filed with ASX · Oct 25, 2017 at 1:50 AM EDT

On 6ix: 6ix.com/news/quarterly-update-and-appendix-4c-26

Pyc Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

PYC Therapeutics Limited on 6ix

Story so far

  • Appendix 4E - Preliminary Final Report 30 June 2017Aug 31, 2017
  • Appendix 4E and Audited Annual Financial StatementsFeb 11, 2016

Earlier from PYC Therapeutics

  • PYC Granted US Patent for Peptides Entering Brain CellsOct 4, 2017
  • New Delivery Vehicles Show Improved Performance Inside CellsSep 5, 2017
  • Appendix 4E - Preliminary Final Report 30 June 2017Aug 31, 2017
  • Response to ASX QueryJul 24, 2017
  • Operational Update June quarterJul 10, 2017

Later from PYC Therapeutics

  • Phylogica Strategic Update - Pivot to PlatformDec 3, 2017
  • FPP Results Effective in Delivering Peptide Cancer VaccineJan 8, 2018
  • Federal R&D Tax Credit ReceivedJan 11, 2018
  • Dec Quarterly Update and Appendix 4CJan 31, 2018
  • Dec 2017 Half-year financial statements & Appendix 4DFeb 28, 2018
All PYC Therapeutics news releases↗

Follow PYC Therapeutics into a list and get an email when it puts out news.

Follow PYC Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer